Amateur footballers who headed the ball during a competitive match showed greater immediate rises in blood markers associated with neural damage than teammates and opponents who did not head, according to a prospective, population-based case-control study published in JAMA Neurology on May 18, 2026. Researchers at Amsterdam UMC, working with the Royal Dutch Football Association, screened 389 players and followed 302 male amateurs (mean age 24.6 years) across 11 organised matches played between August and December 2024. Blood was drawn before the match, within an hour of the final whistle, and again 24 to 48 hours later; video was used to count every header and to classify high-impact headers as those following a ball flight of more than 20 metres.

Heading was common and unremarkable: 216 players (72 percent) headed at least once, averaging 2.0 headers each, and 48 percent took at least one high-impact header. Players exposed to heading had significantly larger post-match increases in S100B, a protein released by glial cells, than unexposed players (P =.03; Cohen d = 0.29). The more headers a player took, the larger the increase in both S100B (d = 0.07 per header) and p-tau217, a phosphorylated tau protein used as a blood marker in Alzheimer's disease research (d = 0.09 per header). High-impact headers were associated with the largest changes (p-tau217 d = 0.40; S100B d = 0.43). All the elevations had normalised within 24 to 48 hours, and no other biomarker associations reached significance.

The findings land in an active policy argument. On June 5, 2025, the Health Council of the Netherlands advised limiting exposure to repeated head contact in sport, with particular attention to children, after reviewing evidence that former professional players face raised rates of dementia and other neurodegenerative disease. The Royal Dutch Football Association introduced heading guidelines for the 2025/26 season: a maximum of 5 to 10 headers per training session for players under 12, 5 to 12 for those aged 12 to 19, and no more than 15 headers from long balls of over 20 metres for seniors, with recovery days advised afterwards. This study measures a single match, not a career, but it is the kind of exposure data governing bodies cite when they set or resist such limits.

The effect sizes are small, the design is observational, and the study cannot show that a transient blood change does lasting harm. Marsh Koenigs, one of the researchers, said the concern is "not the rise in biomarkers itself but rather what it reflects". The principal investigator, neurologist Jort Vijverberg, was blunter about the boundary, saying the study does not tell us about permanent damage to the brain. Only adult men were studied, in one match each; the authors call for longitudinal work to test whether repeated short-lived elevations accumulate into anything clinically meaningful.